Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

EMEA (Europe, Middle East and Africa) Trastuzumab Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Purchase Options

 
In this report, the EMEA Trastuzumab market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Trastuzumab for these regions, from 2018 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Trastuzumab market competition by top manufacturers/players, with Trastuzumab sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Human Source
Animal Source

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Trastuzumab for each application, including
Hospital
Medical Center

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Trastuzumab Market Report 2019
1 Trastuzumab Overview
1.1 Product Overview and Scope of Trastuzumab
1.2 Classification of Trastuzumab
1.2.1 EMEA Trastuzumab Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA Trastuzumab Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Human Source
1.2.4 Animal Source
1.3 EMEA Trastuzumab Market by Application/End Users
1.3.1 EMEA Trastuzumab Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Hospital
1.3.3 Medical Center
1.4 EMEA Trastuzumab Market by Region
1.4.1 EMEA Trastuzumab Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of Trastuzumab (2014-2024)
1.5.1 EMEA Trastuzumab Sales and Growth Rate (2014-2024)
1.5.2 EMEA Trastuzumab Revenue and Growth Rate (2014-2024)

2 EMEA Trastuzumab Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Trastuzumab Market Competition by Players/Manufacturers
2.1.1 EMEA Trastuzumab Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA Trastuzumab Revenue and Share by Players (2014-2019)
2.1.3 EMEA Trastuzumab Sale Price by Players (2014-2019)
2.2 EMEA Trastuzumab (Volume and Value) by Type/Product Category
2.2.1 EMEA Trastuzumab Sales and Market Share by Type (2014-2019)
2.2.2 EMEA Trastuzumab Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA Trastuzumab Sale Price by Type (2014-2019)
2.3 EMEA Trastuzumab (Volume) by Application
2.4 EMEA Trastuzumab (Volume and Value) by Region
2.4.1 EMEA Trastuzumab Sales and Market Share by Region (2014-2019)
2.4.2 EMEA Trastuzumab Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA Trastuzumab Sales Price by Region (2014-2019)

3 Europe Trastuzumab (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Trastuzumab Sales and Value (2014-2019)
3.1.1 Europe Trastuzumab Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe Trastuzumab Revenue and Growth Rate (2014-2019)
3.2 Europe Trastuzumab Sales and Market Share by Type
3.3 Europe Trastuzumab Sales and Market Share by Application
3.4 Europe Trastuzumab Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Trastuzumab Sales Volume by Countries (2014-2019)
3.4.2 Europe Trastuzumab Revenue by Countries (2014-2019)
3.4.3 Germany Trastuzumab Sales and Growth Rate (2014-2019)
3.4.4 France Trastuzumab Sales and Growth Rate (2014-2019)
3.4.5 UK Trastuzumab Sales and Growth Rate (2014-2019)
3.4.6 Russia Trastuzumab Sales and Growth Rate (2014-2019)
3.4.7 Italy Trastuzumab Sales and Growth Rate (2014-2019)
3.4.8 Benelux Trastuzumab Sales and Growth Rate (2014-2019)

4 Middle East Trastuzumab (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Trastuzumab Sales and Value (2014-2019)
4.1.1 Middle East Trastuzumab Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East Trastuzumab Revenue and Growth Rate (2014-2019)
4.2 Middle East Trastuzumab Sales and Market Share by Type
4.3 Middle East Trastuzumab Sales and Market Share by Application
4.4 Middle East Trastuzumab Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Trastuzumab Sales Volume by Countries (2014-2019)
4.4.2 Middle East Trastuzumab Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia Trastuzumab Sales and Growth Rate (2014-2019)
4.4.4 Israel Trastuzumab Sales and Growth Rate (2014-2019)
4.4.5 UAE Trastuzumab Sales and Growth Rate (2014-2019)
4.4.6 Iran Trastuzumab Sales and Growth Rate (2014-2019)

5 Africa Trastuzumab (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Trastuzumab Sales and Value (2014-2019)
5.1.1 Africa Trastuzumab Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa Trastuzumab Revenue and Growth Rate (2014-2019)
5.2 Africa Trastuzumab Sales and Market Share by Type
5.3 Africa Trastuzumab Sales and Market Share by Application
5.4 Africa Trastuzumab Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Trastuzumab Sales Volume by Countries (2014-2019)
5.4.2 Africa Trastuzumab Revenue by Countries (2014-2019)
5.4.3 South Africa Trastuzumab Sales and Growth Rate (2014-2019)
5.4.4 Nigeria Trastuzumab Sales and Growth Rate (2014-2019)
5.4.5 Egypt Trastuzumab Sales and Growth Rate (2014-2019)
5.4.6 Algeria Trastuzumab Sales and Growth Rate (2014-2019)

6 EMEA Trastuzumab Manufacturers/Players Profiles and Sales Data
6.1 Genentech Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Trastuzumab Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genentech Inc Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Trastuzumab Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Trastuzumab Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Trastuzumab Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abnova Corporation Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 InvivoGen
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Trastuzumab Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 InvivoGen Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Celltrion
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Trastuzumab Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Celltrion Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Biocon Limited
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Trastuzumab Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Limited Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Bio-Techne
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Trastuzumab Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bio-Techne Trastuzumab Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview

7 Trastuzumab Manufacturing Cost Analysis
7.1 Trastuzumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Trastuzumab

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Trastuzumab Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Trastuzumab Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Trastuzumab Market Forecast (2019-2024)
11.1 EMEA Trastuzumab Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA Trastuzumab Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA Trastuzumab Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA Trastuzumab Price and Trend Forecast (2019-2024)
11.2 EMEA Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa Trastuzumab Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA Trastuzumab Sales Forecast by Type (2019-2024)
11.7 EMEA Trastuzumab Sales Forecast by Application (2019-2024)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us